{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:01:09Z","timestamp":1791165669847,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking University People\u2019s Hospital Scientific Research Development Funds","award":["RDJ2022-09"],"award-info":[{"award-number":["RDJ2022-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04125-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:34:24Z","timestamp":1776767664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Global trends of tranexamic acid in cardiac surgery: a bibliometric and visualized analysis via CiteSpace"],"prefix":"10.1186","volume":"21","author":[{"given":"Liang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"1","key":"4125_CR1","doi-asserted-by":"publisher","first-page":"E039","DOI":"10.1532\/hsf.2797","volume":"23","author":"L Sun","year":"2020","unstructured":"Sun L, An H, Feng Y. Intravenous tranexamic acid decreases blood transfusion in off-pump coronary artery bypass surgery: a meta-analysis. Heart Surg Forum. 2020;23(1):E039\u201349.","journal-title":"Heart Surg Forum"},{"issue":"3","key":"4125_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00228-025-03802-0","volume":"81","author":"T Nakai","year":"2025","unstructured":"Nakai T, Tamura T, Miyagawa Y, Inagaki T, Mutsuga M, Yamada S, et al. Population pharmacokinetic model of tranexamic acid in patients who undergo cardiac surgery with cardiopulmonary bypass. Eur J Clin Pharmacol. 2025;81(3):441\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"22","key":"4125_CR3","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","volume":"358","author":"DA Fergusson","year":"2008","unstructured":"Fergusson DA, Hebert PC, Mazer CD, Fremes S, Macadams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319\u201331.","journal-title":"N Engl J Med"},{"key":"4125_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5798","volume":"345","author":"B Hutton","year":"2012","unstructured":"Hutton B, Joseph L, Fergusson D, Mazer CD, Shapiro S, Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ. 2012;345:e5798.","journal-title":"BMJ"},{"issue":"2","key":"4125_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0971-9784.109749","volume":"16","author":"A Dhir","year":"2013","unstructured":"Dhir A. Antifibrinolytics in cardiac surgery. Ann Card Anaesth. 2013;16(2):117\u201325.","journal-title":"Ann Card Anaesth"},{"key":"4125_CR6","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2025.04.034","author":"L La Via","year":"2025","unstructured":"La Via L, Cuttone G, Terranova C, Sorbello M, Martucci G, Pappalardo F. Optimizing tranexamic acid use in adult cardiac surgery: from rationale to clinical practice. J Cardiothorac Vasc Anesth. 2025. https:\/\/doi.org\/10.1053\/j.jvca.2025.04.034.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"Suppl 1(Suppl 1","key":"4125_CR7","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","volume":"101","author":"C Chen","year":"2004","unstructured":"Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101(Suppl 1(Suppl 1)):5303\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4125_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14712598.2012.674507","volume":"12","author":"C Chen","year":"2012","unstructured":"Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12(5):593\u2013608.","journal-title":"Expert Opin Biol Ther"},{"issue":"46","key":"4125_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039945","volume":"103","author":"X Chen","year":"2024","unstructured":"Chen X, Cao Y, Huang S, Chen Y, Zhang C. Current status and hotspots in breast cancer patient self-management research: a bibliometric and visual analysis via CiteSpace. Medicine (Baltimore). 2024;103(46):e39945.","journal-title":"Medicine (Baltimore)"},{"key":"4125_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.1094959","volume":"13","author":"D Yang","year":"2022","unstructured":"Yang D, Wu X, Liu J, Zhou J. CiteSpace-based global science, technology, engineering, and mathematics education knowledge mapping analysis. Front Psychol. 2022;13:1094959.","journal-title":"Front Psychol"},{"issue":"22","key":"4125_CR11","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1161\/CIRCULATIONAHA.106.671222","volume":"115","author":"JR Brown","year":"2007","unstructured":"Brown JR, Birkmeyer NJO, O\u2019Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115(22):2801\u201313.","journal-title":"Circulation"},{"issue":"3","key":"4125_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1067\/mtc.2000.108016","volume":"120","author":"V Casati","year":"2000","unstructured":"Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg. 2000;120(3):520\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"4125_CR13","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/S0003-4975(99)00866-8","volume":"68","author":"V Casati","year":"1999","unstructured":"Casati V, Guzzon D, Oppizzi M, Cossolini M, Torri G, Calori G, et al. Hemostatic effects of aprotinin, tranexamic acid and \u03b5-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg. 1999;68(6):2252\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4125_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.jvca.2004.01.016","volume":"18","author":"S Chauhan","year":"2004","unstructured":"Chauhan S, Das SN, Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18(2):141\u20133.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"4125_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1213\/ane.0b013e318182252b","volume":"107","author":"W Dietrich","year":"2008","unstructured":"Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, et al. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg. 2008;107(5):1469\u201378.","journal-title":"Anesth Analg"},{"issue":"1","key":"4125_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1185\/030079903125002658","volume":"20","author":"K Hekmat","year":"2004","unstructured":"Hekmat K, Zimmermann T, Kampe S, Kasper SM, Weber HJ, Geissler HJ, et al. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Curr Med Res Opin. 2004;20(1):121\u20136.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"4125_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.athoracsur.2008.03.033","volume":"86","author":"G Lindvall","year":"2008","unstructured":"Lindvall G, Sartipy U, Ivert T, van der Linden J. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery. Ann Thorac Surg. 2008;86(1):13\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"4125_CR18","first-page":"401","volume":"37","author":"A Menichetti","year":"1996","unstructured":"Menichetti A, Tritapepe L, Ruvolo G, Speziale G, Cogliati A, Digiovanni C, et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. J Cardiovasc Surg (Torino). 1996;37(4):401\u20137.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"4","key":"4125_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ejcts.2005.06.027","volume":"28","author":"T Vanek","year":"2005","unstructured":"Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg. 2005;28(4):563\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"4125_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11748-021-01709-y","volume":"70","author":"C Chen","year":"2022","unstructured":"Chen C, Liu J, Du L. Tranexamic acid after cardiopulmonary bypass does not increase risk of postoperative seizures: a retrospective study. Gen Thorac Cardiovasc Surg. 2022;70(4):337\u201346.","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"5","key":"4125_CR21","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.jvca.2017.04.026","volume":"31","author":"P Couture","year":"2017","unstructured":"Couture P, Lebon J, Laliberte E, Desjardins G, Chamberland M, Ayoub C, et al. Low-dose versus high-dose tranexamic acid reduces the risk of nonischemic seizures after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2017;31(5):1611\u20137.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"4125_CR22","first-page":"633","volume":"58","author":"H Takagi","year":"2017","unstructured":"Takagi H, Ando T, Umemoto T. Seizures associated with tranexamic acid for cardiac surgery: a meta-analysis of randomized and non-randomized studies. J Cardiovasc Surg (Torino). 2017;58(4):633\u201341.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"4125_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-019-0761-3","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Bai Y, Chen M, Zhou Y, Yu X, Zhou H, et al. The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials. BMC Anesthesiol. 2019. https:\/\/doi.org\/10.1186\/s12871-019-0761-3.","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"4125_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11845-019-01991-z","volume":"188","author":"A Saracoglu","year":"2019","unstructured":"Saracoglu A, Ezelsoy M, Saracoglu KT. Postoperative thrombotic effects of tranexamic acid in open heart surgery. Ir J Med Sci. 2019;188(4):1373\u20138.","journal-title":"Ir J Med Sci"},{"issue":"6","key":"4125_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1213\/ANE.0000000000002724","volume":"127","author":"A Jerath","year":"2018","unstructured":"Jerath A, Yang QJ, Pang KS, Looby N, Reyes-Garces N, Vasiljevic T, et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg. 2018;127(6):1323\u201332.","journal-title":"Anesth Analg"},{"issue":"2","key":"4125_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1606424","volume":"376","author":"PS Myles","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376(2):136\u201348.","journal-title":"N Engl J Med"},{"key":"4125_CR27","volume":"17","author":"L Sanchez Salcedo","year":"2023","unstructured":"Sanchez Salcedo L, Manuel Baloira F, Adrover A, Bianco JC, Garcia Guzzo ME. Tranexamic acid in cardiac surgery: a case report of an infrequent adverse reaction to a common medication. A A Pract. 2023;17:e0173011.","journal-title":"A A Pract"},{"issue":"129","key":"4125_CR28","first-page":"34","volume":"19","author":"J Guo","year":"2019","unstructured":"Guo J, Gao X, Ma Y, Lv H, Hu W, Zhang S, et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol. 2019;19(129):34.","journal-title":"BMC Anesthesiol"},{"issue":"01","key":"4125_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0042-1760205","volume":"72","author":"A Koster","year":"2024","unstructured":"Koster A, Hulde N, Deutsch M, Gummert JFF, von Dossow V, Zittermann A. The efficacy and safety of a low-dose tranexamic acid bolus-only protocol compared with the moderate-dose protocol in valvular heart surgery. Thorac Cardiovasc Surg. 2024;72(01):55\u20138.","journal-title":"Thorac Cardiovasc Surg"},{"key":"4125_CR30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1791233","author":"HS Rangwala","year":"2025","unstructured":"Rangwala HS, Rangwala BS, Alotaibi M, Siddiq MA, Qamber A, Zaidi SDEZ, et al. Clinical outcomes with high- versus low-dose tranexamic acid infusion in patients undergoing cardiac surgery: a systematic review and meta-analysis. Thorac Cardiovasc Surg. 2025. https:\/\/doi.org\/10.1055\/s-0044-1791233.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"4","key":"4125_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jama.2022.10725","volume":"328","author":"J Shi","year":"2022","unstructured":"Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, et al. Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery The OPTIMAL Randomized Clinical Trial. JAMA. 2022;328(4):336\u201347.","journal-title":"JAMA"},{"issue":"8A","key":"4125_CR32","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1053\/j.jvca.2021.12.029","volume":"36","author":"ER Strauss","year":"2022","unstructured":"Strauss ER, Li S, Henderson R, Carpenter R, Guo D, Thangaraju K, et al. A pharmacokinetic and plasmin-generation pharmacodynamic assessment of a tranexamic acid regimen designed for cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2022;36(8A):2473\u201382.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"4125_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/ALN.0000000000000570","volume":"122","author":"MC Wesley","year":"2015","unstructured":"Wesley MC, Pereira LM, Scharp LA, Emani SM Jr., Mcgowan FX, Dinardo JA. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2015;122(4):746\u201358.","journal-title":"Anesthesiology"},{"issue":"6","key":"4125_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.bja.2024.03.023","volume":"132","author":"R Yoshii","year":"2024","unstructured":"Yoshii R, Takahashi Y, Tanaka KA, Kawajiri H, Sawa T, Amaya F, et al. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients. Br J Anaesth. 2024;132(6):1211\u20138.","journal-title":"Br J Anaesth"},{"issue":"6","key":"4125_CR35","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jtcvs.2012.11.042","volume":"145","author":"AFL Later","year":"2013","unstructured":"Later AFL, Sitniakowsky LS, van Hilten JA, van de Watering L, Brand A, Smit NPM, et al. Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145(6):1611.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4125_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.951835","volume":"9","author":"C Xie","year":"2022","unstructured":"Xie C, Yao Y, He L, Yang K. Anti-inflammatory effect of tranexamic acid on adult cardiac surgical patients: a PRISMA-compliant systematic review and meta-analysis. Front Surg. 2022;9:951835.","journal-title":"Front Surg"},{"issue":"1","key":"4125_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1460-9592.2004.01366.x","volume":"15","author":"FS Bulutcu","year":"2005","unstructured":"Bulutcu FS, \u00f6zbek U, Polat B, Yal\u00e7in Y, Karaci AR, Bayindir O. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth. 2005;15(1):41\u20136.","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"4125_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1537-2995.2006.00724.x","volume":"46","author":"K Karkouti","year":"2006","unstructured":"Karkouti K, Beattie WS, Dattilo KM, Mccluskey SA, Ghannam M, Hamdy A, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46(3):327\u201338.","journal-title":"Transfusion"},{"issue":"3","key":"4125_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12630-008-9038-x","volume":"56","author":"A Abrishami","year":"2009","unstructured":"Abrishami A, Chung F, Wong J. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth. 2009;56(3):202\u201312.","journal-title":"Can J Anaesth"},{"issue":"5","key":"4125_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/ejcts\/ezs127","volume":"42","author":"D Faraoni","year":"2012","unstructured":"Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012;42(5):781\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"4125_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1503\/cmaj.081109","volume":"180","author":"D Henry","year":"2009","unstructured":"Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. Can Med Assoc J. 2009;180(2):183\u201393.","journal-title":"Can Med Assoc J"},{"key":"4125_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058009","volume":"8","author":"P Meybohm","year":"2013","unstructured":"Meybohm P, Herrmann E, Nierhoff J, Zacharowski K. Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and \u03b5-aminocaproic acid - a meta-analysis of randomised and observational trials of over 30.000 patients. PLoS ONE. 2013;8:e580093.","journal-title":"PLoS ONE"},{"issue":"2","key":"4125_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/PCC.0b013e3181956d61","volume":"10","author":"ES Schouten","year":"2009","unstructured":"Schouten ES, van de Pol AC, Schouten ANJ, Turner NM, Jansen NJG, Bollen CW. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis. Pediatr Crit Care Med. 2009;10(2):182\u201390.","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"4125_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3126\/nhj.v20i2.59444","volume":"20","author":"BK Shrestha","year":"2023","unstructured":"Shrestha BK, Khadka R, Bhusal S, Baidya R, Bhandari S, Suraj KC. A randomized comparison of two doses of tranexamic acid in high-risk open-heart surgery. Nepal Heart J. 2023;20(2):1\u20136.","journal-title":"Nepal Heart J"},{"issue":"2","key":"4125_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/02676591241242641","volume":"40","author":"W Chen","year":"2025","unstructured":"Chen W, Du Z, Wang L, Wang M, Wang H, Hou X. The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery. Perfusion. 2025;40(2):475\u201382.","journal-title":"Perfusion"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04125-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04125-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04125-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:02:13Z","timestamp":1780448533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04125-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4125"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04125-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}